Dr Reddy’s Debuts US Vimovo Rival At Risk

Lupin Has Authorized Generic As Nuvo Cites Patents To 2022

 
• By Dave Wallace
  
Risk
Dr Reddy’s launch of a Vimovo rival is at risk • Source: Shutterstock

More from Products

More from Generics Bulletin